Drug intelligence / Profile preview

foot-and-mouth disease virus synthetic peptide vaccine

Development stage
Unknown
Lead developer
Shenlian Biotech
Modality
Peptides, Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

The **foot-and-mouth disease virus synthetic peptide vaccine** is a veterinary vaccine developed by **Shen Lian Biotech** for the prevention of Foot-and-Mouth Disease (FMD) in livestock, particularly swine and cattle. It represents a significant technological milestone as the first synthetic peptide vaccine for FMD to be commercialized globally. The vaccine is composed of chemically synthesized peptides that mimic the immunodominant epitopes of the Foot-and-Mouth Disease Virus (FMDV) capsid protein, specifically the G-H loop of the VP1 protein. Unlike traditional inactivated vaccines, this synthetic approach eliminates the risk of incomplete virus inactivation or virus escape during the manufacturing process. Furthermore, it allows for the **Differentiation of Infected from Vaccinated Animals (DIVA)**, as the vaccine only contains specific viral peptides rather than the full array of viral proteins. It is approved in China and has been widely utilized in national compulsory immunization programs to control FMD outbreaks.

Brand names
Shen Lian
Other names
口蹄疫合成肽疫苗FMD synthetic peptide vaccineFoot-and-mouth disease virus type O synthetic peptide vaccineKoutiyi Hechengtai Yimiao
02

Targets

FMDV VP1 G-H loop (Foot-and-mouth disease virus VP1 G-H loop)

Beyond the preview

Go deeper on foot-and-mouth disease virus synthetic peptide vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on foot-and-mouth disease virus synthetic peptide vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call